The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
bimatoprost · Gel
3 marketed package NDCs · 1 active manufacturer
Most dispensed: .3 mg/mL · Solution/ Drops · #1 bottle/carton / 5 ml in 1 bottle · .3 mg/mL · Solution/ Drops · #1 bottle/carton / 2.5 ml in 1 bottle · .3 mg/mL · Solution/ Drops · #1 bottle/carton / 7.5 ml in 1 bottle · .1 mg/mL · Solution/ Drops · #1 bottle/carton / 2.5 ml in 1 bottle
What changed in the last 90 days
Every detected change for bimatoprost, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- BimatoprostAug 19, 2026Price downNADAC $5.0298 → $4.23499 per unit (-15.8%)
- BimatoprostAug 19, 2026Price upNADAC $8.20042 → $8.87231 per unit (+8.19%)
- BimatoprostAug 19, 2026Price upNADAC $7.07356 → $7.33963 per unit (+3.76%)
- BimatoprostAug 19, 2026Price downNADAC $55.70261 → $50.31455 per unit (-9.67%)
- BimatoprostAug 19, 2026Price downNADAC $50.17136 → $49.00717 per unit (-2.32%)
- BimatoprostAug 19, 2026Price downNADAC $55.74054 → $50.40188 per unit (-9.58%)
- BimatoprostAug 19, 2026Price downNADAC $5.0298 → $4.23499 per unit (-15.8%)
- BimatoprostAug 19, 2026Price upNADAC $8.20042 → $8.87231 per unit (+8.19%)
- BimatoprostAug 19, 2026Price upNADAC $7.07356 → $7.33963 per unit (+3.76%)
- BimatoprostAug 19, 2026Price upNADAC $7.07356 → $7.33963 per unit (+3.76%)
Same drug class
Other molecules FDA puts in Prostaglandin Analog, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- tafluprost opthalmic· 1 maker
- travoprost (isomer free)· 1 maker
- travoprost ophthalmic solution usp, 0.004%· 1 maker
- travoprost ophthalmic solution, 0.004%· 1 maker
- travoprost intracameral· 2 makers
- travoprost ophthalmic· 2 makers
- travoprost ophthalmic solution· 4 makers
- dinoprostone· 7 makers
- tafluprost· 12 makers
- travoprost· 16 makers
- alprostadil· 18 makers
- carboprost tromethamine· 26 makers
Common questions
- Is Bimatoprost in shortage right now?
- No. FDA does not currently list Bimatoprost in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Bimatoprost?
- 38 companies have marketed Bimatoprost in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Bimatoprost cost?
- The typical pharmacy pays about $8.87 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.